Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements
August 13, 2018 07:55 ET
|
Innovest Global, Inc
CLEVELAND, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the “Company” or “Innovest”), a Conglomerate with operations in commercial and industrial products and...
GeoVax and Emory University to Collaborate on HPV Therapeutic Program for Head and Neck Cancers
July 30, 2018 09:00 ET
|
GeoVax, Inc.
GeoVax Continues Expansion of its MVA-VLP Vaccine Pipeline with Multiple Collaborations in Infectious Disease and Immuno-oncology ATLANTA, GA, July 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc....
Innovest Global Announces Patent is Approved for StemVax Therapeutics
July 25, 2018 08:30 ET
|
Innovest Global, Inc
CLEVELAND, July 25, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Pink Current:IVST) (the “Company” or “Innovest”), reports that the patent application for the technology being developed by...
Innovest Global Acquires Stake in StemVax Therapeutics, Launching Biotechnology & Health Services Division
July 18, 2018 08:30 ET
|
Innovest Global, Inc
CLEVELAND, July 18, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Pink Current:IVST) (the “Company” or “Innovest”), a diversified holding company with operations in commercial and industrial...
Investigators Dose First Patient in Phase 1 Study of Treos Bio’s PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer
May 14, 2018 08:15 ET
|
Treos Bio Corp.
SAN FRANCISCO and LONDON, May 14, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion...
Treos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer
April 11, 2018 08:15 ET
|
Treos Bio Corp.
SAN FRANCISCO and LONDON, April 11, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion...
Treos Bio Names Gábor Illés as Its Chief Financial Officer
April 03, 2018 08:15 ET
|
Treos Bio Corp.
SAN FRANCISCO and LONDON, April 03, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion...
Innovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences Company
March 19, 2018 08:00 ET
|
Innovest Global, Inc
CLEVELAND, March 19, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC PINK: IVST) announces it has signed a Letter of Intent to acquire a 20% stake in StemVax LLC. StemVax is a Translational...
Treos Bio Announces FDA Approval of IND of Its First PolyPEPI™ Precision Cancer Vaccine for Metastatic Colorectal Cancer
January 24, 2018 08:15 ET
|
Treos Bio Corp.
SAN FRANCISCO and LONDON, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion...
Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022: Download Report, Market Opportunity at USD 100 Billion, Clinical Trial Insight by Drug Class
June 26, 2017 04:12 ET
|
KuicK Research
NEW DELHI, India, June 26, 2017 (GLOBE NEWSWIRE) -- Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 report highlights: Cancer Immunotherapy Market Assessment by ClassCancer...